A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges.
about
Common stemness regulators of embryonic and cancer stem cellsFibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implicationsTargeting Hsp90 in urothelial carcinomaMolecular mechanisms of fibroblast growth factor signaling in physiology and pathologyBladder CancerFrequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease.Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis.Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCRCrosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug ResistanceNovel molecular targets for urothelial carcinomaPhosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics.Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models.Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerFibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial CarcinomaTrichlorobenzene-substituted azaaryl compounds as novel FGFR inhibitors exhibiting potent antitumor activity in bladder cancer cells in vitro and in vivoFibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup.The route to personalized medicine in bladder cancer: where do we stand?microRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer.Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014.FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro.FGFs: crucial factors that regulate tumour initiation and progression.Canine and human sarcomas exhibit predominant FGFR1 expression and impaired viability after inhibition of signaling.Sleeping beauty: awakening urothelium from its slumber.The evolving genomic landscape of urothelial carcinoma.Oncogenic FGFR3 gene fusions in bladder cancer.Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer.TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer.Identification of an Indazole-Based Pharmacophore for the Inhibition of FGFR Kinases Using Fragment-Led de Novo Design.Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer.FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer.Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression.Differential Expression of FGFRs Signaling Pathway Components in Bladder Cancer: A Step Toward Personalized Medicine.
P2860
Q26777882-471DBB59-7D86-4E67-BCFD-383ADB2D542CQ26801718-0E612475-5464-464F-B553-4CFA562AA77EQ27023406-C4DF638A-BF81-423E-A65D-8601D387E02EQ28291993-3EF53644-B4F8-418B-B67F-B93145FA93A2Q30230812-E32CABBF-D4BA-48D0-AD0D-5DDAC9A3EF65Q33583057-A8479BE7-1C64-48CA-A3BB-86DBBBF5207EQ33646072-6CE78C36-2818-4007-ACE9-6380D306784FQ35047444-AD0E14F8-7DE2-420B-803F-B79B2BDF4801Q35143027-1D8FCFE8-2542-4A23-9767-7BA29E601B40Q35527068-5A993233-5823-4CFA-A664-AF5FE786BC68Q35604069-1CCA6C87-185A-48D3-ACEB-E4747D973BD1Q35864528-7E7D90BB-E291-4A3B-946E-37DE31BD47FDQ35948339-5F140607-4571-4AD2-AF04-37F357938292Q36040421-3B9FFC6F-22A4-40C2-82D6-16BA15115B5FQ37053820-773C6FEB-4EE1-4E95-80F1-4617627A9C83Q37110135-553E6368-03A0-4EC6-B855-F6778278B7D9Q37295668-49908DA5-7A10-43B5-9905-8CCA546E99B8Q37687627-C1228A40-DC10-4AB1-9754-449EEAB5E000Q38337192-F0EA0B71-62E2-4516-A680-E691DCE506A3Q38379205-A6A802A5-3210-493F-9905-D3F702992CC1Q38692457-635C927A-321D-4CF9-B586-85F67CFCAA80Q38731392-7056EE28-9079-4182-A058-ED686FB33033Q38868203-633F44FB-5FC6-4708-9CF7-177C7B5B973DQ38887615-B9C45E2C-916D-41EF-80F3-5ED6778F4DE7Q39005693-4340A063-2E7A-4965-B3EF-F527E1842140Q39103374-7D1C52BA-3DFD-4722-A33D-CF73A5CC2711Q39124491-97B9176C-0DAA-4A04-9516-DB706B24648AQ39240290-AD7EDC61-5BEF-4395-980F-18FBDA62FE15Q40622697-EB22830E-C9D9-4457-992C-D641C80FBCC4Q43148228-2C73583F-F4B9-47E4-B18D-7A8D98C9D328Q49865845-F120FF3C-A875-41DB-AE44-B4085F70FB1EQ50064953-94970B14-A133-4574-9820-E8264CE0D610Q52804812-0EF89D1E-2C6D-488F-933F-50AFACF7895FQ54347333-EC3F0725-9E79-4349-B7E2-8CE32859DC05Q54348729-BA9AA4D2-E70B-4F64-90E1-F2E1B9F3BEEEQ54985778-EEF358D8-23FD-4537-8A56-BE8002BF8B42Q55040613-1FA15742-2909-463D-AE96-593E4133DDA7Q55052397-E5D68C32-E416-4504-9F7B-EE0BC8FB80DD
P2860
A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@en
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@en-gb
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@nl
type
label
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@en
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@en-gb
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@nl
prefLabel
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@en
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@en-gb
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@nl
P2860
P50
P356
P1433
P1476
A Decade of FGF Receptor Resea ...... resent, and Future Challenges.
@en
P2860
P304
P356
10.1155/2012/429213
P577
2012-07-31T00:00:00Z